Shilpi Singh

2.2k total citations
41 papers, 1.2k citations indexed

About

Shilpi Singh is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Shilpi Singh has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Shilpi Singh's work include Phytochemicals and Antioxidant Activities (7 papers), Synthesis and biological activity (6 papers) and Natural product bioactivities and synthesis (6 papers). Shilpi Singh is often cited by papers focused on Phytochemicals and Antioxidant Activities (7 papers), Synthesis and biological activity (6 papers) and Natural product bioactivities and synthesis (6 papers). Shilpi Singh collaborates with scholars based in India, United States and Taiwan. Shilpi Singh's co-authors include Suaib Luqman, Abha Meena, Pratima Gupta, J. Hans van Leeuwen, Basudeb Saha, Maohong Fan, Vijaya Dubey, Dhananjay Kumar Singh, Ateeque Ahmad and Mahendra P. Darokar and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Biochemical Pharmacology.

In The Last Decade

Shilpi Singh

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilpi Singh India 18 402 206 185 148 142 41 1.2k
Christine Hoelzl Austria 14 330 0.8× 192 0.9× 124 0.7× 78 0.5× 105 0.7× 16 1.0k
Nirmalendu Das India 27 539 1.3× 464 2.3× 309 1.7× 194 1.3× 107 0.8× 95 2.0k
Dongwook Kim South Korea 18 594 1.5× 267 1.3× 102 0.6× 195 1.3× 185 1.3× 72 1.9k
Mousa O. Germoush Saudi Arabia 23 464 1.2× 216 1.0× 168 0.9× 317 2.1× 97 0.7× 69 1.7k
Jie Kang China 25 816 2.0× 326 1.6× 160 0.9× 89 0.6× 229 1.6× 89 1.9k
Poyil Pratheeshkumar United States 29 1.3k 3.2× 316 1.5× 246 1.3× 145 1.0× 152 1.1× 66 2.7k
Abha Meena India 22 579 1.4× 219 1.1× 200 1.1× 121 0.8× 136 1.0× 75 1.5k
Ardhendu Mandal India 20 384 1.0× 100 0.5× 77 0.4× 84 0.6× 49 0.3× 57 1.3k
Ajaz Ahmad Saudi Arabia 22 331 0.8× 330 1.6× 84 0.5× 197 1.3× 192 1.4× 55 1.4k

Countries citing papers authored by Shilpi Singh

Since Specialization
Citations

This map shows the geographic impact of Shilpi Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpi Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpi Singh more than expected).

Fields of papers citing papers by Shilpi Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpi Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpi Singh. The network helps show where Shilpi Singh may publish in the future.

Co-authorship network of co-authors of Shilpi Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Shilpi Singh. A scholar is included among the top collaborators of Shilpi Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilpi Singh. Shilpi Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Shilpi, Debashis Barik, Haoyi Zheng, et al.. (2025). Harnessing ferroptosis to transform glioblastoma therapy and surmount treatment resistance. Cell Death Discovery. 11(1). 448–448. 1 indexed citations
2.
Singh, Gatikrushna, Shilpi Singh, Mayur Sharma, et al.. (2025). Feedforward miR-181d degradation modulates population variance of methyl-guanine methyl transferase and temozolomide resistance. Cell Reports. 44(11). 116516–116516.
3.
Prasad, Sujata, et al.. (2024). Gut redox and microbiome: charting the roadmap to T-cell regulation. Frontiers in Immunology. 15. 1387903–1387903. 9 indexed citations
5.
Singh, Shilpi, Debashis Barik, Sujata Prasad, et al.. (2023). Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment. International Journal of Molecular Sciences. 24(19). 14960–14960. 16 indexed citations
6.
Singh, Shilpi, et al.. (2023). Myricitrin from bayberry as a potential inhibitor of cathepsin-D: Prospects for squamous lung carcinoma prevention. Food and Chemical Toxicology. 179. 113988–113988. 3 indexed citations
7.
Singh, Shilpi, et al.. (2023). Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(6). 130340–130340. 5 indexed citations
8.
Singh, Shilpi, et al.. (2023). Myricetin 3-rhamnoside retards the proliferation of hormone-independent breast cancer cells by targeting hyaluronidase. Journal of Biomolecular Structure and Dynamics. 42(19). 10311–10322. 3 indexed citations
10.
Singh, Shilpi, et al.. (2021). Acacetin and pinostrobin as a promising inhibitor of cancer-associated protein kinases. Food and Chemical Toxicology. 151. 112091–112091. 18 indexed citations
11.
Singh, Shilpi, Waseem Raza, Shahnaz Parveen, Abha Meena, & Suaib Luqman. (2021). Flavonoid display ability to target microRNAs in cancer pathogenesis. Biochemical Pharmacology. 189. 114409–114409. 18 indexed citations
12.
Singh, Shilpi, Jyoti Singh, Yusuf Hussain, et al.. (2020). Pharmacology of Carissa carandas leaf extract: anti-proliferative, antioxidant and antimicrobial investigation. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 155(3). 543–556. 4 indexed citations
13.
Singh, Shilpi, Abha Meena, & Suaib Luqman. (2020). Baicalin mediated regulation of key signaling pathways in cancer. Pharmacological Research. 164. 105387–105387. 123 indexed citations
14.
Singh, Shilpi, Pratima Gupta, Abha Meena, & Suaib Luqman. (2020). Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders. Food and Chemical Toxicology. 145. 111708–111708. 151 indexed citations
15.
Singh, Shilpi, et al.. (2019). Microwave-assisted Single Step Cinnamic Acid Derivatization and Evaluation for Cytotoxic Potential. Current Pharmaceutical Biotechnology. 21(3). 236–243. 2 indexed citations
16.
Gupta, Priyanka, Shilpi Singh, Madhuri Gupta, et al.. (2018). Antioxidant, antimicrobial activities and comparative analysis of the composition of essential oils of leaf, stem, flower and aerial part of Nepeta hindostana. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 153(2). 242–249. 2 indexed citations
17.
Singh, Shilpi, et al.. (2018). Rutin protects t‑butyl hydroperoxide-induced oxidative impairment via modulating the Nrf2 and iNOS activity. Phytomedicine. 55. 92–104. 69 indexed citations
18.
Singh, Shilpi, Vijaya Dubey, Abha Meena, et al.. (2018). Rutin restricts hydrogen peroxide-induced alterations by up-regulating the redox-system: An in vitro, in vivo and in silico study. European Journal of Pharmacology. 835. 115–125. 18 indexed citations
19.
Singh, Dhananjay Kumar, Archana Saxena, Shilpi Singh, et al.. (2017). Fraxetin and ethyl acetate extract from Lawsonia inermis L. ameliorate oxidative stress in P. berghei infected mice by augmenting antioxidant defence system. Phytomedicine. 36. 262–272. 31 indexed citations
20.
Fan, Maohong, et al.. (2007). Evaluation of iron oxide and aluminum oxide as potential arsenic(V) adsorbents. Chemical Engineering and Processing - Process Intensification. 46(10). 1030–1039. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026